Matches in SemOpenAlex for { <https://semopenalex.org/work/W2285947501> ?p ?o ?g. }
- W2285947501 endingPage "35" @default.
- W2285947501 startingPage "1028" @default.
- W2285947501 abstract "A salvage program including infusional high-dose ifosfamide plus etoposide (IFOVM) was evaluated in patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.Forty-six patients were included. IFOVM consisted of ifosfamide (10 g/m2 as a 72-hour continuous infusion), etoposide (900 mg/m2) and methylprednisolone; responding patients underwent two cycles of DHAP and subsequently an autologous peripheral blood stem cell transplantation (APBSCT) with BEAM as the conditioning regimen.All but one patient showed tumor regression following IFOVM. Myelosuppression was brief but 26 patients developed neutropenic fever. All but two patients proceeded to DHAP. Overall response rate to IFOVM/DHAP was 59% (29% CR and 30% PR). Refractory patients had a significantly lower response rate than relapsed patients (39% vs. 85% p=0.002). All refractory patients with intermediate-high or high IPI progressed during IFOVM/DHAP. Twenty-seven patients proceeded to APBSCT. Two-year overall survival of patients with low or low-intermediate IPI was 47% [95% CI 25-69%], which was significantly better than that obtained in patients with intermediate-high or high IPI (11% [95% CI 0-22%] p=0.0001).This sequential regimen of IFOVM, followed by DHAP and consolidated with BEAM is active in relapsed or refractory patients with low or low-intermediate IPI aggressive lymphoma. However, it has little activity in those patients with intermediate or high IPI, especially in refractory lymphomas." @default.
- W2285947501 created "2016-06-24" @default.
- W2285947501 creator A5010206363 @default.
- W2285947501 creator A5010733763 @default.
- W2285947501 creator A5016510706 @default.
- W2285947501 creator A5054988858 @default.
- W2285947501 creator A5056641413 @default.
- W2285947501 creator A5068240503 @default.
- W2285947501 creator A5071568118 @default.
- W2285947501 creator A5076822049 @default.
- W2285947501 creator A5080567561 @default.
- W2285947501 creator A5089188528 @default.
- W2285947501 date "2002-10-01" @default.
- W2285947501 modified "2023-10-17" @default.
- W2285947501 title "High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma." @default.
- W2285947501 cites W1533253784 @default.
- W2285947501 cites W1580788756 @default.
- W2285947501 cites W1605164920 @default.
- W2285947501 cites W1759931359 @default.
- W2285947501 cites W1793094955 @default.
- W2285947501 cites W1816898406 @default.
- W2285947501 cites W1822252547 @default.
- W2285947501 cites W1830589476 @default.
- W2285947501 cites W1834370350 @default.
- W2285947501 cites W1836056413 @default.
- W2285947501 cites W1888347784 @default.
- W2285947501 cites W1895128059 @default.
- W2285947501 cites W1912693401 @default.
- W2285947501 cites W1933973263 @default.
- W2285947501 cites W1977507357 @default.
- W2285947501 cites W1979300931 @default.
- W2285947501 cites W1987239762 @default.
- W2285947501 cites W1997353354 @default.
- W2285947501 cites W2023242031 @default.
- W2285947501 cites W2035615319 @default.
- W2285947501 cites W2038169321 @default.
- W2285947501 cites W2058015212 @default.
- W2285947501 cites W2063553062 @default.
- W2285947501 cites W2076261964 @default.
- W2285947501 cites W2077060193 @default.
- W2285947501 cites W2083809451 @default.
- W2285947501 cites W2094773778 @default.
- W2285947501 cites W2100643883 @default.
- W2285947501 cites W2104795464 @default.
- W2285947501 cites W2107202569 @default.
- W2285947501 cites W2117964879 @default.
- W2285947501 cites W2123351934 @default.
- W2285947501 cites W2134808252 @default.
- W2285947501 cites W2154537768 @default.
- W2285947501 cites W2173600563 @default.
- W2285947501 cites W2187668060 @default.
- W2285947501 cites W2204433245 @default.
- W2285947501 cites W2263814165 @default.
- W2285947501 cites W2312895077 @default.
- W2285947501 cites W2333286024 @default.
- W2285947501 cites W2408960595 @default.
- W2285947501 cites W2466983854 @default.
- W2285947501 cites W3024436806 @default.
- W2285947501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12368156" @default.
- W2285947501 hasPublicationYear "2002" @default.
- W2285947501 type Work @default.
- W2285947501 sameAs 2285947501 @default.
- W2285947501 citedByCount "6" @default.
- W2285947501 countsByYear W22859475012016 @default.
- W2285947501 countsByYear W22859475012017 @default.
- W2285947501 countsByYear W22859475012020 @default.
- W2285947501 countsByYear W22859475012022 @default.
- W2285947501 crossrefType "journal-article" @default.
- W2285947501 hasAuthorship W2285947501A5010206363 @default.
- W2285947501 hasAuthorship W2285947501A5010733763 @default.
- W2285947501 hasAuthorship W2285947501A5016510706 @default.
- W2285947501 hasAuthorship W2285947501A5054988858 @default.
- W2285947501 hasAuthorship W2285947501A5056641413 @default.
- W2285947501 hasAuthorship W2285947501A5068240503 @default.
- W2285947501 hasAuthorship W2285947501A5071568118 @default.
- W2285947501 hasAuthorship W2285947501A5076822049 @default.
- W2285947501 hasAuthorship W2285947501A5080567561 @default.
- W2285947501 hasAuthorship W2285947501A5089188528 @default.
- W2285947501 hasConcept C121332964 @default.
- W2285947501 hasConcept C126322002 @default.
- W2285947501 hasConcept C141071460 @default.
- W2285947501 hasConcept C142424586 @default.
- W2285947501 hasConcept C181199279 @default.
- W2285947501 hasConcept C185592680 @default.
- W2285947501 hasConcept C2776694085 @default.
- W2285947501 hasConcept C2777506904 @default.
- W2285947501 hasConcept C2778119113 @default.
- W2285947501 hasConcept C2779050716 @default.
- W2285947501 hasConcept C2779617269 @default.
- W2285947501 hasConcept C2780372218 @default.
- W2285947501 hasConcept C2780775027 @default.
- W2285947501 hasConcept C2781413609 @default.
- W2285947501 hasConcept C2911091166 @default.
- W2285947501 hasConcept C55493867 @default.
- W2285947501 hasConcept C71924100 @default.
- W2285947501 hasConcept C87355193 @default.
- W2285947501 hasConcept C90924648 @default.
- W2285947501 hasConceptScore W2285947501C121332964 @default.